Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Karyopharm Therapeutics Inc.
DescriptionSmall molecule inhibitor of p21 protein (Cdc42 Rac)-activated kinase 4 (PAK4) and nicotinamide phosphoribosyltransferase (NamPRT; NAMPT)
Molecular Target p21 protein (Cdc42 Rac)-activated kinase 4 (PAK4) ; Nicotinamide phosphoribosyltransferase (NamPRT) (NAMPT)
Mechanism of ActionNicotinamide phosphoribosyl transferase inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today